{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-018540","form_type":"8-K","ticker":"RVPH","cik":"0001742927","company_name":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","filed_at":"2024-05-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.849818+00:00","generated_at":"2026-06-01T07:43:35.229691+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Reviva announces $3M registered direct offering of 1.9M shares and warrants at $1.58/unit","bullets":["Sold 1,898,734 shares and warrants at $1.58/unit; warrants exercisable at $1.455 for 5 years.","Net proceeds ~$3.0M; funds Phase 3 RECOVER-2 trial and working capital.","Existing Nov 2023 warrants (1,365,854 shares, $5.00 exercise) amended to $1.455, extended 5 years.","H.C. Wainwright placement agent; cash fee 6% of gross proceeds.","Closing expected May 29, 2024, subject to customary conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-018540","json":"https://secwatch.observer/filing/0001437749-24-018540.json","markdown":"https://secwatch.observer/filing/0001437749-24-018540.md","text":"https://secwatch.observer/filing/0001437749-24-018540.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1742927/000143774924018540/0001437749-24-018540-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1742927/000143774924018540/rvph20240528_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:43:35.229691+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}